Trials / Completed
CompletedNCT01062971
Clinical Study of A Fixed Combination of Timolol-Brimonidine-Dorzolamide
Comparative Clinical Study of The Safety And Efficacy of A New Fixed-Combination of Timolol-Brimonidine-Dorzolamide In Patients With Open Angle Glaucoma Or Ocular Hypertension
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 124 (actual)
- Sponsor
- Laboratorios Sophia S.A de C.V. · Industry
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
To compare intraocular pressure lowering effectiveness of a new fixed combination drug.
Detailed description
This is a multicentric, double blind and prospective clinical study. We will include patients with confirmed diagnosis of primary open-angle glaucoma and/or ocular hypertension, with intraocular pressure (IOP) ranging between 21 and 31 mm Hg. Patients will be randomly divided into 2 groups, one of them treated with a new formulation of 0.5% timolol-0.2% brimonidine-2% dorzolamide in fixed combination (Krytantek Ofteno®, Laboratorios Sophia, Mexico) and the other one treated with 0.5% timolol-2% dorzolamide fixed combination (Cosopt®, MSD Laboratories, USA). Patients will receive 1 drop twice a day of either formulations and were examined at days 2, 7, 15, 30, 60, and 90 after initiation of treatment. The primary objective is to compare the efficacy of both formulations, estimated as a decrease in IOP. A Goldmann applanation tonometer will be used for IOP determination.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | dorzolamide-timolol-brimonidine | Patients will be randomly divided into 2 groups, one of them treated with a new formulation of 0.5% timolol-0.2% brimonidine-2% dorzolamide in fixed combination (Krytantek Ofteno®, Laboratorios Sophia, Mexico) and the other one treated with 0.5% timolol-2% dorzolamide fixed combination (Cosopt®, MSD Laboratories, USA). Patients will received 1 drop twice a day of either formulations. |
Timeline
- Start date
- 2006-02-01
- Primary completion
- 2007-08-01
- Completion
- 2008-06-01
- First posted
- 2010-02-04
- Last updated
- 2019-08-01
- Results posted
- 2019-08-01
Locations
1 site across 1 country: Mexico
Source: ClinicalTrials.gov record NCT01062971. Inclusion in this directory is not an endorsement.